Skip to content
Hei Āhuru Mōwai, Māori Cancer Leadership Aotearoa
Donate
MenuClose

Blood cancers

On this page: resources published by other organisations, then documents held in our own library, then the research assessed for this site.

This page points at research, and at resources published by other organisations. It is not advice about your own care or treatment.

Research

One paper on blood cancers, from the research assessed for this site. Each is summarised below in words written for this site, not the authors’ own.

  1. Blood cancer incidence, mortality and survival for Māori in New Zealand (opens on the publisher’s website)

    Cancer Epidemiology · 2024

    Clough S, Wheeler M, Stanley J, Signal V, Ruka M, Koea J, Gurney J

    What it found
    Using national Cancer Registry data from 2007 to 2019 (2,653 Māori and 20,458 European blood cancer registrations), the study found Māori were more likely than Europeans to be diagnosed with, and to die from, leukaemia and myeloma, and had similar rates of Hodgkin and non-Hodgkin lymphoma. Māori had poorer cancer-specific survival across nearly all blood cancer types – age-sex-adjusted hazard ratios were 1.77 for leukaemia, 1.71 for non-Hodgkin lymphoma, 1.40 for myeloma and 1.18 for Hodgkin lymphoma, the last with a wide confidence interval reflecting the small number of cases. Within leukaemia, the survival gap was narrowest under 25 and widest in the 25–64 age bands. The authors call for further research to pinpoint where in the pathway the survival gap arises.
    How it was done
    retrospective national registry cohort, 2,653 Māori and 20,458 European blood cancer registrations, NZ Cancer Registry 2007–2019, linked to mortality data to 2018
    Why it matters
    It gives registry-level numbers, not an estimate, for a group of cancers that gets less attention in Māori cancer commentary than the larger solid-tumour cancers.
    What it does not settle
    A registry and mortality-linkage study can show the size of a gap but not explain it. The authors themselves flag the Hodgkin lymphoma estimate as imprecise because of low case numbers.

    Full textFull text, via the published version of record (CC BY, Otago OUR Archive).

    Read it free: Blood cancer incidence, mortality and survival for Māori in New Zealand (opens on another organisation’s website)DOI 10.1016/j.canep.2024.102656

How this page was put together

The research summaries

Each summary was written for this site, and it is not the authors’ own abstract. None of it has been reviewed by Hei Āhuru Mōwai. It was read in full. Each entry carries the note of what was read, because a summary built from an abstract carries less weight than one built from the paper.

Resources published by other organisations

Each one opens a record on this site naming the publisher, carrying their own note about the edition and about how they are funded where they give one. The document itself is on the publisher’s website. None of it is hosted here, and it remains theirs.

Which of these appear, and how they are grouped, is a choice made for this site. It is not Hei Āhuru Mōwai’s view on what any of them says.

Looking for something else

All cancer types, or the whole library at Rauemi.

If you cannot find what you are after, get in touch.